PROGRESSION
P169: PROTEOMIC ANALYSIS OF MOUSE KIDNEY TISSUE FOLLOWING SUB-TOTAL NEPHRECTOMY
ME Vickers, Sheffield Kidney Institute

P170: MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN PROGRESSIVE KIDNEY SCARRING
AK Ahmed, Sheffield Kidney Institute

P171: UPREGULATION OF TISSUE TRANSGLUTAMINASE IN TRANSFORMING GROWTH FACTOR-? INDUCED EPITHELIAL MESENCHYMAL TRANSDIFFERENTIATION IN RAT TUBULAR EPITHELIAL CELLS
E Parker, Sheffield Kidney Institute

P172: RHOC IS A KEY SIGNALLING MOLECULE IN THE PROCESS OF EPITHELIAL TO MESENCHYMAL TRANSITION
N Hutchison, King's College London

P173: EFFECT OF TRANSGLUTAMINASE INHIBITION ON MACROPHAGE INFILTRATION IN EXPERIMENTAL KIDNEY DISEASE
L Huang, Sheffield Kidney Institute

P174: IS ENDOCYTOSIS REQUIRED FOR ALBUMIN MEDIATED SECRETION OF TGF? -1 IN PROXIMAL TUBULAR EPITHELIAL CELLS (PTECS)?
R Diwakar, St Helier Hospital, Carshalton

P175: ASSOCIATION BETWEEN THE METABOLISM OF HYALURONAN AND FIBROBLAST PHENOTYPE
S Meran, University Hospital of Wales

P176: ASSOCIATION BETWEEN GLUCOSE TRANSPORTER 1 (GLUT 1) GENE PROMOTER POLYMORPHISM A-2841T AND END STAGE RENAL DISORDER (ESRD) IN CAUCASOID PATIENTS
B Shirodkar, Derriford Hospital, Plymouth

P177: PRIMARY TUBULAR EPITHELIAL CELLS ISOLATED FROM THE TISSUE TRANSGLUTAMINASE KNOCKOUT MOUSE DEPOSIT LESS EXTRACELLULAR MATRIX THAN WILD TYPE CELLS
M Fisher, Sheffield Kidney Institute

P178: ALBUMIN OVERLOAD INDUCES ADAPTIVE RESPONSES IN HUMAN PROXIMAL TUBULAR CELLS THROUGH OXIDATIVE STRESS BUT NOT VIA ANGIOTENSIN II TYPE 1 RECEPTOR
L Shalamanova, University of Liverpool

GLOMERULAR DISEASE
P179: HIGH INCIDENCE, LATE PRESENTATION AND POOR OUTCOME OF ANTI-GBM DISEASE IN LANCASHIRE AND SOUTH CUMBRIA, 1995-2005.
IK Szeki, Royal Preston Hospital

P180: INDUCTION OF MUCOSAL TOLERANCE IN EXPERIMENTAL AUTOIMMUNE GLOMERULONEPHRITIS BY NASAL ADMINISTRATION OF AN IMMUNODOMINANT PEPTIDE FROM RAT ?3(IV)NC1 CONJUGATED TO CHOLERA TOXIN B SUBUNIT
J Reynolds, Imperial College London

P181: ANCA-ASSOCIATED RENAL VASCULITIS: OUTCOMES IN 78 PATIENTS FROM A SINGLE-CENTRE, 7-YEAR RETROSPECTIVE STUDY
WS Priestman, Derby City Hospital

P182: SIRNA KNOCKDOWN OF T-TYPE CALCIUM CHANNELS INHIBITS HUMAN MESANGIAL CELL PROLIFERATION
CJ Mulgrew, King's College London

P183: OUTCOME OF ACUTE RENAL FAILURE IN ANCA ASSOCIATED RENAL VASCULITIS (AARV) - A 10 YEAR RETROSPECTIVE STUDY
U.P. Udayaraj, Churchill Hospital, Oxford

P184: RITUXIMAB AND REFRACTORY ANCA ASSOCIATED VASCULITIS; IS LOW CD4 COUNT DETRIMENTAL?
CF Wong, Royal Liverpool University Hospital

P185: STRUCTURAL AND PROMOTER POLYMORPHISMS OF MANNOSE BINDING LECTIN ARE NOT ASSOCIATED WITH SMALL VESSEL VASCULITIS OR TREATMENT RELATED INFECTIONS
L Kamesh, University of Birmingham

P186: PODOCYTURIA: A USEFUL TEST FOR PROGRESSIVE RENAL DISEASE?
IA Ihmoda, University of Edinburgh

P187: INCREASED GLOMERULAR MRNA EXPRESSION OF THE P2X7 RECEPTOR IN EXPERIMENTAL GLOMERULONEPHRITIS IS ASSOCIATED WITH AN INCREASE IN P53 AND BAX
C.M. Turner, Royal Free and UCL Medical School, London

P188: EFFECTS OF PALMITATE AND ROSIGLITAZONE ON THE INSULIN SENSITIVITY OF HUMAN PODOCYTES
R Lennon, Southmead Hopsital, Bristol

P189: USE OF MYCOPHENOLATE MOFETIL TO STABILISE DETERIORATING RENAL FUNCTION IN GLOMERULAR DISEASE
V Suresh, Southmead Hopsital, Bristol

NUTRITION 2     
P190: ROLE OF DIETARY ADVICE TO RESTRICT SALT INTAKE ON SODIUM EXCRETION IN RENAL STONE DISEASE PATIENTS
V Suresh, Southmead Hopsital, Bristol

P191: DEVELOPMENT OF A PATIENT CENTRED DIETETIC TRANSPLANT SERVICE
J Wyllie, Royal Free Hospital, London

P192: IDENTIFYING BARRIERS TO NUTRITIONAL CARE ON AN ACUTE RENAL WARD: QUALITATIVE STUDY
HA Sadler, Derriford Hospital, Plymouth

P193: WITHDRAWN

P194: SEGMENTAL SINGLE FREQUENCY BIO IMPEDANCE IS ASSOCIATED WITH APPENDICULAR LEAN MASS IN PATIENTS AS THEY COMMENCE DIALYSIS THERAPY
H Campbell,Leeds General Infirmary

P195: COULD NEW TEACHING AIDS IMPROVE PATIENTS KNOWLEDGE ON PHOSPHATE MANAGEMENT
S Gray, Queen Elizabeth Hospital, Birmingham

P196: CAN SERUM CARNITINE BE USED AS A MARKER OF NUTRITIONAL STATUS IN PERITONEAL DIALYSIS PATIENTS?
JM Hill, Royal Free Hospital, London

PSYCHOSOCIAL CARE      
P197: AN EXPLORATORY SURVEY OF PATIENTS WITH RENAL DISEASE TO IDENTIFY ISSUES CONCERNING EMOTIONAL AND PHYSICAL RELATIONSHIPS
B Fentum, Leicester General Hospital

P198: DIAGNOSING DEPRESSION IN END-STAGE RENAL DISEASE. THE BECKS DEPRESSION INVENTORY AND A CLINICAL INTERVIEW: A COMPARATIVE STUDY
D Grant, Mascall's Park, Essex

P199: ARE PREDIALYSIS PATIENTS RECEIVING INFORMATION TO MEET THEIR NEEDS? A STUDY OF A TEACHING PROGRAMME FOR PATIENTS WITH CHRONIC RENAL FAILURE
W.A Ashton, Cumberland Infirmary, Carlisle

P200: THE IMPORTANCE OF A NEEDS ASSESSMENT IN PLACING RESOURCES TO INTRODUCE A PROGRAMME FOR INCREASED EDUCATION AND AWARENESS OF EARLY CKD
NJ McIntyre, Nottingham City Hospital

ACCESS (HAEMODIALYSIS)    
P201: THE INCIDENCE OF VASCULAR ACCESS RELATED BACTERAEMIA IS DEPENDENT MORE ON THE TYPE OF LONG-TERM HAEMODIALYSIS ACCESS THAN ON PATIENT RELATED FACTORS
E Mazonakis, Western Infirmary of Glasgow

P202: TREATMENT OF ACUTE THROMBOSIS OF NATIVE ARTERIOVENOUS FISTULAE BY SURGICAL THROMBECTOMY
M Ferring, Birmingham Heartlands Hospital

P203: EARLY RESULTS WITH THE TRANSONIC (r) DEVICE IN DETECTING ACCESS STENOSIS.
M Heap, Lancashire Teaching Hospitals

P204: THE TARGETED USE OF TAUROLOCK IN REDUCTION OF EPISODES OF LINE SEPSIS IN THE 'HIGH RISK' HAEMODIALYSIS POPULATION
MA Vernon, Royal Infirmary of Edinburgh

HAEMODIALYSIS 3
P205: REMOVAL OF SERUM FREE LIGHT CHAINS BY HAEMODIALYSIS IN PATIENTS WITH MULTIPLE MYELOMA.
C.A. Hutchison, Queen Elizabeth Medical Centre, Birmingham

P206: A COMPARISON OF QUALITY OF LIFE AT COMMENCEMENT AND 3 MONTHS POST HAEMODIALYSIS BETWEEN PATIENTS KNOWN TO NEPHROLOGY SERVICES AND "LATE REFERRALS" IN SOUTH EAST WALES.
V Lodhi, University Hospital of Wales

P207: HAEMODYNAMIC & RENIN-ANGIOTENSIN SYSTEM RESPONSES TO FLUID ULTRAFILTRATION IN HAEMODIALYSIS PATIENTS
TWR Doulton, St. George's, University of London

P208: FIVE YEARS SURVIVAL ON HAEMODIALYSIS (HD) PREDICTED BY ARTIFICIAL NEURAL NETWORK (ANN) MODEL
BA Ahmed, Sheffield Kidney Institute

P209: OXIDATIVE STRESS AND MARKERS OF VASCULAR ABNORMALITIES IN MAINTENANCE HAEMODIALYSIS (HD)
BA Ahmed, Sheffield Kidney Institute

P210: DEVELOPMENT OF A FLUID ASSESSMENT TOOL TO AID NURSING ASSESSMENT OF DRY WEIGHT
C A Fielding, Derby City General Hospital

P211: EQUITY OF ACCESS TO RRT - A COMPARISON OF NEW DIALYSIS PATIENTS IN 2 GEOGRAPHICALLY CLOSE RENAL UNITS
CH Jones, York Hospital

P212: REDUCED RESTING BAROREFLEX SENSITIVITY IS AN IMPORTANT DETERMINANT OF AN ABERRANT HAEMODYNAMIC RESPONSE DURING HAEMODIALYSIS
LJ Chesterton, Derby City General Hospital

P213: DIALYSIS SURVIVORS: CLINICAL OUTCOMES IN DIALYSIS PATIENTS ON TREATMENT FOR MORE THAN 10 YEARS
D Ashby, Hammersmith Hospital, London

P214: QUANTIFYING FLUID SHIFTS DURING HAEMODIALYSIS WITH PROFILED ULTRAFILTRATION
S Mitra, Manchester Royal Infirmary

P215: IMPLEMENTATION OF HEPATITIS B VACCINATION PROGRAMME FOR MAINTENANCE HAEMODIALYSIS PATIENTS, AND EFFECT OF PATIENT CHARACTERISTIC ON THE RESPONSE RATE
C M A Henson, Macclesfield District General

P216: NO DIFFERENCE IN THE SYSTEMIC INFLAMMATORY RESPONSE SEEN WITH ACETATE FREE DIALYSATE AS COMPARED WITH STANDARD BICARBONATE DIALYSIS
NM Selby, Derby City Hospital

TRANSPLANT (BASIC SCIENCE)      
P217: CASPASE-3 ACTIVATION IN ASSESSING VIABILITY OF ISOLATED PORCINE KIDNEYS UNDERGOING WARM ISCHAEMIA AND NORMOTHERMIC REPERFUSION
B Yang, Leicester General Hospital

P218: THE EFFECT OF BODY TEMPERATURE IN RAT MODEL OF RENAL ISCHAEMIA-REPERFUSION INJURY
MS Delbridge, Sheffield Kidney Institute

P219: FTY720 REDUCES ISCHAEMIA-REPERFUSION INDUCED INJURY IN RAT KIDNEYS
MS Delbridge, Sheffield Kidney Institute

P220: FTY720 REDUCES RENAL FIBROSIS INDUCED BY ISCHAEMIA-REPERFUSION INJURY IN A RAT MODEL
MS Delbridge, Sheffield Kidney Institute

P221: INTERLEUKIN-18 EXPRESSION IS UP REGULATED IN ACUTE RENAL ALLOGRAFT REJECTION AND COLOCALISED TO RESIDENT AND INFILTRATING CELLS
MD Morgan, University of Birmingham

P222: MACROPHAGE MODULATION OF ENDOTHELIAL CELL BIOLOGY: A POSSIBLE MECHANISM FOR MACROPHAGE INVOLVEMENT IN RENAL ALLOGRAFT FAILURE
A Adair, The Queen's Medical Research Institute, Edinburgh

P223: MATRILYSIN (MMP7) PROTECTS GRAFTS FROM REJECTION ACROSS A MINOR MHC MISMATCH IN A MURINE SKIN TRANSPLANTATION MODEL
PE Herbert, Hammersmith Hospital, London
 
GFR   
P224: ESTIMATION OF GLOMERULAR FILTRATION RATE IN PATIENTS WITH CHRONIC RENAL FAILURE: VALIDITY OF A NEW SIMPLE CYSTATIN C-BASED PREDICTION EQUATION.
R Glover, University of Wales

P225: IMPLICATIONS OF ROUTINE REPORTING OF ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) IN SECONDARY CARE
C C Geddes, Western Infirmary, Glasgow

P226: CYSTATIN C AS A SURROGATE FOR GLOMERULAR FILTRATION RATE IN THE PRESENCE OF PROTEINURIA
TA Ledson, Royal Liverpool University Hospital

P227: A PRAGMATIC APPROACH TO REDUCING THE EFFECT OF BIAS IN CREATININE ASSAYS ON EGFR.
SC Smith, University Hospital, Coventry

P228: CAN COMPENSATED JAFFE ASSAYS BE SUBSTITUTED INTO THE MDRD FORMULA TO ESTIMATE GFR - A COMPARISON WITH ID-MS?
E J Lamb, Kent and Canterbury Hospital

P229: CALIBRATING CREATININE ASSAYS TO THE MDRD CLEVELAND CLINIC LABORATORY SIGNIFICANTLY INFLUENCES ESTIMATES OF THE PREVALENCE OF CKD IN ENGLAND
P E Stevens, Kent and Canterbury Hospital

P230: AT WHAT LEVEL DOES QUANTIFICATION OF ESTIMATED GFR CEASE TO BECOME USEFUL?
M Kao, Ninewells Hospital, Dundee

P231: ESTIMATED GFR: DO PATIENTS KNOW AND DO THEY CARE?
N Leonard, Belfast City Hospital

P232: PREDICTION OF GLOMERULAR FILTRATION RATE IS IMPROVED BY DIRECTLY MEASURING BODY COMPOSITION
JH Macdonald, University of Wales
 
ANAEMIA  
P233: NEW IRON DEFICIENCY TESTING STRATEGIES IN CHRONIC KIDNEY DISEASE PATIENTS
S Kallankara, Hull Royal Infirmary

P234: THE FIRST CASE OF PURE RED CELL APLASIA (PRCA) ASSOCIATED WITH ANTI-ERYTHROPOIETIN ANTIBODIES IN A PATIENT RECEIVING SOLE TREATMENT WITH DARBEPOETIN ALFA
SJ Harper, Southmead Hospital, Bristol

P235: CONVERSION FROM INTRAVENOUS ERYTHROPOIETIN-ALFA (EPREX(r)) TO INTRAVENOUS DARBOPOIETIN (ARANESP(r)): EXTENDED FOLLOW-UP OF HAEMODIALYSIS PATIENTS IN A SINGLE CENTRE
S El Yar, St Luke's Hospital, Bradford

P236: POST-TRANSPLANT ANAEMIA ACCELERATES RATE OF PROGRESSION OF RENAL DYSFUNCTION
S Shah, William Harvey Research Institute, London

P237: A RETROSPECTIVE STUDY OF THE EFFECT OF INCREASING FREQUENCY OF ADMINISTRATION OF INTRAVENOUS EPOETIN ON RENAL ANAEMIA IN HAEMODIALYSIS PATIENTS
E Critchley, Royal Shrewsbury Hospital
 
DIABETES   
P238: GLUCOSE-ENRICHED DIALYSATE CAUSES DETERIORATION IN POST-DIALYSIS COGNITIVE FUNCTION DESPITE MILD HYPERGLYCAEMIA
C Firth, Leeds General Infirmary

P239: DIABETIC NEPHROPATHY - A ONE-YEAR ANALYSIS OF A LOCAL COHORT
E A Garthwaite, York Hospital

P240: GLUCOSE-CONTAINING DIALYSIS FLUID FOR PATIENTS ON HAEMODIALYSIS: A SINGLE CENTRE CONVERSION STUDY
R Lawton, St Luke's Hospital, Bradford

P241: RENAL ABNORMALITIES IN PATIENTS ATTENDING A HOSPITAL DIABETIC SERVICE IN A DISTRICT GENERAL HOSPITAL: AN AUDIT OF COMPLIANCE WITH RECOMMENDED STANDARDS OF CARE
SL Jones, Nottingham City Hospital

P242: FREE LIGHT CHAIN ABNORMALITIES IN DIABETIC PATIENTS WITH AND WITHOUT MICROALBUMINURIA.
C.A. Hutchison, Queen Elizabeth Medical Centre, Birmingham
CARDIOVASCULAR RISK 2 
P243: THE HAEMODYNAMIC EFFECTS OBSERVED DURING PD FLUID DRAINAGE AND INSTILLATION DO NOT ADVERSELY AFFECT REGIONAL LV FUNCTION OR TROPONIN T LEVELS
NM Selby, Derby City Hospital

P244: CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN URAEMIC PATIENTS AND THEIR ASSOCIATION WITH CARDIOVASCULAR DISEASE
M J Blunden, Royal London Hospital

P245: PRESENCE OF CORONARY ARTERY CALCIFICATION IN A GROUP OF STAGE 3 AND 4 CHRONIC KIDNEY DISEASE PATIENTS
CJ Porter, Nottingham City Hospital

P246: CIRCULATING LEVELS OF FETUIN-A ARE NOT ASSOCIATED WITH VC OR SYSTEMIC INFLAMMATION IN CKD 4, PERITONEAL OR HAEMODIALYSIS PATIENTS
MK Sigrist, Derby City Hospital

P247: EFFECTIVENESS OF A CARDIOVASCULAR RISK FACTOR MODIFICATION PROGRAM IN INSULIN-RESISTANT RENAL TRANSPLANT RECIPIENT
K Armstrong, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

P248: EFFECT OF AGGRESSIVE RISK FACTOR MODIFICATION ON CARDIAC EVENTS AND MYOCARDIAL ISCHAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
DJ Rakhit, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

P249: FUNCTION AND CRYSTAL STRUCTURE OF CLEC-2 AT 1.6 ANGSTROMS RESOLUTION
C.A O'Callaghan, University of Oxford

P250: ELECTROCARDIOGRAPHY AND ECHOCARDIOGRAPHY COMPARED TO CARDIOVASCULAR MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF LEFT VENTRICULAR HYPERTROPHY IN END STAGE RENAL FAILURE
PB Mark, University of Glasgow

P251: THE RELATIONSHIP BETWEEN CARDIOVASCULAR RISK FACTORS, MYOCARDIAL DAMAGE AND AORTIC DISTENSIBILTY AS ASSESSED USING CARDIOVASCULAR MRI IN END STAGE RENAL FAILURE
PB Mark, University of Glasgow

P252: SUBCLINICAL ATHEROSCEROTIC CHANGES IN EARLY CKD
FH Ibrahim, Sheffield Kidney Institute